Today before the opening bell, VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology, and drug metabolism screening, told investors that Shawn K. Singh, CEO of VistaGen, will be stepping into the spotlight at Noble Financial Capital Markets’ Ninth Annual Equity Conference.
Mr. Singh’s presentation will provide a comprehensive overview of the company’s progress and unique opportunities to apply its stem cell technology platform, Human Clinical Trials in a Test Tube™, for drug rescue, predictive toxicology, and drug metabolism screening. He will present at 12:30 pm EST on Wednesday, January 23, 2013, at the Hard Rock Hotel in Hollywood, Florida.
Those who wish to access the presentation materials as well as tune-in remotely via a live audio and video webcast should visit VistaGen’s website at www.vistagen.com and Noble Financial’s website at www.noblefcm.com. Investors and analysts should register approximately 10 minutes before the start of the presentation to ensure timely access.
Let us hear your thoughts below: